- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Aliquots are pre-aliquoted, commercially available drugs from the EU. Our aliquots thus contain therapeutic molecules manufactured by the original drug license holder and repackaged by Evidentic.
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
05/2019 |
276,30 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
01/2019 |
276,30 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
09/2020 |
276,30 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
11/2020 |
276,30 € |
||
PD-1 |
Monoclonal Antibody |
Opdivo® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2021 |
276,30 € |
||
CD20 |
Monoclonal Antibody |
Gazyvaro® |
25 mg/mL |
– |
6 mg |
-80°C |
06/2019 |
279,90 € |
||
CD20 |
Monoclonal Antibody |
Gazyvaro® |
25 mg/mL |
– |
6 mg |
-80°C |
08/2019 |
279,90 € |
||
CD20 |
Monoclonal Antibody |
Ocrevus® |
30 mg/mL |
– |
3 mg |
-80°C |
08/2021 |
395,10 € |
||
CD20 |
Monoclonal Antibody |
Ocrevus® |
30 mg/mL |
yes |
3 mg |
-80°C |
02/2021 |
395,10 € |
||
CD20 |
Monoclonal Antibody |
Ocrevus® |
30 mg/mL |
– |
3 mg |
-80°C |
01/2022 |
395,10 € |
||
CD20 |
Monoclonal Antibody |
Ocrevus® |
30 mg/mL |
yes |
3 mg |
-80 °C |
09/2022 |
395,10 € |
||
CD20 |
Monoclonal Antibody |
Ocrevus® |
30 mg/mL |
– |
3 mg |
-80°C |
11/2024 |
439,00 € |
||
Clotting Factor VIII |
Recombinant protein |
Advate® |
125 IU/mL |
– |
25 IU |
-80°C |
09/2022 |
414,90 € |
||
IgE |
Monoclonal Antibody |
Xolair® |
150 mg/mL |
– |
6 mg |
-80 °C |
09/2023 |
284,40 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
04/2019 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
06/2019 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
10/2019 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
02/2020 |
391,50 € |
||
Respiratory syncytial virus (RSV) |
Monoclonal Antibody |
Synagis® |
100 mg/mL |
yes |
4 mg |
-80°C |
08/2020 |
391,50 € |
||
EGFR |
Monoclonal Antibody |
Vectibix® |
20 mg/mL |
– |
2 mg |
-80 °C |
02/2025 |
230,00 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
07/2018 |
451,80 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
12/2018 |
451,80 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
03/2019 |
451,80 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
07/2019 |
451,80 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
yes |
2 mg |
-80°C |
04/2022 |
564,30 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
11/2022 |
451,80 € |
||
PD-1 |
Monoclonal Antibody |
Keytruda® |
25 mg/mL |
– |
2 mg |
-80°C |
04/2024 |
502,00 € |
||
HER2 |
Monoclonal Antibody |
Perjeta® |
30 mg/mL |
yes |
6 mg |
-80°C |
11/2020 |
419,40 € |
||
CD79b |
Antibody-drug conjugate (ADC) |
Polivy® |
20 mg/mL |
– |
1 mg |
-80 °C |
06/2024 |
536,00 € |
||
VEGFR2 |
Monoclonal Antibody |
Cyramza® |
10 mg/mL |
– |
2 mg |
-80°C |
03/2018 |
182,70 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin